Karen May-Newman

Dr. Karen May-Newman


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Journal of Biomechanics
Verified
Journal Article
Closed access
KWK. Wong
K. Wong
GSG. Samaroo
G. Samaroo
ILI. Ling
I. Ling
WDW. Dembitsky
W. Dembitsky
RAR. Adamson
R. Adamson
KMKaren May-Newman
Karen May-Newman

1 July 2010 in ASAIO Journal
Verified
Journal Article
Closed access
KMKaren May-Newman
Karen May-Newman
LELuz Enriquez-Almaguer
Luz Enriquez-Almaguer
PPPhanthiwa Posuwattanakul
Phanthiwa Posuwattanakul
WDWalter Dembitsky
Walter Dembitsky
The biomechanics of the aortic valve are altered in patients with ventricular assist devices (VADs). During high VAD flow and low cardiac function, transvalvular pressure is high, and the aortic valve remains closed throughout the cardiac cycle. This condition has been linked to the development of aortic valve fusion and incompetence during VAD use. Thus, physicians try to maintain pulsatile flow to assure periodic valve opening. The aim of this study was to determine the extent of aortic valve opening and alterations in valve leaflet strain before and during VAD support using a specially designed mock loop. The results showed that diastole is prolonged during VAD use. In addition, there is a reduction in valve opening area, producing a VAD-related functional stenosis. The average leaflet strain increased during VAD support, primarily due to an increase in the minimum strain, during systole, rather than the maximum strain during diastole. The findings support our hypothesis that altered biomechanics in the VAD-assisted heart results in increased strain in the aortic valve leaflets, which can stimulate soft tissue remodeling. The implication for clinical use is that valve opening during parallel VAD flow is reduced compared with normal flow conditions. Consequently, current clinical practice for VAD patients may not be achieving sufficient valve opening to prevent changes such as fusion and incompetence.

13 June 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ASAlfonso Santiago
Alfonso Santiago
CBConstantine Butakoff
Constantine Butakoff
BEBeatriz Eguzkitza
Beatriz Eguzkitza
RGRichard A. Gray
Richard A. Gray
KMKaren May-Newman
Karen May-Newman
MVMariano Vázquez
Mariano Vázquez
Background: Left ventricular assist devices (LVADs) are implantable pumps that act as a life support therapy for patients with severe heart failure. Despite improving the survival rate, LVAD therapy can carry major complications. Particularly, the flow distortion introduced by the LVAD in the left ventricle (LV) may induce thrombus formation. While previous works have used numerical models to study the impact of multiple variables in the intra-LV stagnation regions, a comprehensive validation analysis has never been executed. The main goal of this work is to present a model of the LV-LVAD system and to design and follow a verification, validation and uncertainty quantification (VVUQ) plan based on the ASME V&V40 and V&V20 standards to ensure credible predictions. Methods: The experiment used to validate the simulation is the SDSU cardiac simulator, a bench mock-up of the cardiovascular system that allows mimicking multiple operation conditions for the heart-LVAD system. The numerical model is based on Alya, the BSC’s in-house platform for numerical modelling. Alya solves the Navier-Stokes equation with an Arbitrary Lagrangian-Eulerian (ALE) formulation in a deformable ventricle and includes pressure-driven valves, a 0D Windkessel model for the arterial output and a LVAD boundary condition modeled through a dynamic pressure-flow performance curve. The designed VVUQ plan involves: (a) a risk analysis and the associated credibility goals; (b) a verification stage to ensure correctness in the numerical solution procedure; (c) a sensitivity analysis to quantify the impact of the inputs on the four quantities of interest (QoIs) (average aortic root flow Q A o a v g , maximum aortic root flow Q A o m a x , average LVAD flow Q V A D a v g , and maximum LVAD flow Q V A D m a x ); (d) an uncertainty quantification using six validation experiments that include extreme operating conditions. Results: Numerical code verification tests ensured correctness of the solution procedure and numerical calculation verification showed a grid convergence index (GCI)95% <3.3%. The total Sobol indices obtained during the sensitivity analysis demonstrated that the ejection fraction, the heart rate, and the pump performance curve coefficients are the most impactful inputs for the analysed QoIs. The Minkowski norm is used as validation metric for the uncertainty quantification. It shows that the midpoint cases have more accurate results when compared to the extreme cases. The total computational cost of the simulations was above 100 [core-years] executed in around three weeks time span in Marenostrum IV supercomputer. Conclusions: This work details a novel numerical model for the LV-LVAD system, that is supported by the design and execution of a VVUQ plan created following recognised international standards. We present a methodology demonstrating that stringent VVUQ according to ASME standards is feasible but computationally expensive.

1 July 2013 in ASAIO Journal
Verified
Journal Article
Closed access
KMKaren May-Newman
Karen May-Newman
YWYork Kin Wong
York Kin Wong
RARobert Adamson
Robert Adamson
PHPeter Hoagland
Peter Hoagland
VVVi Vu
Vi Vu
WDWalter Dembitsky
Walter Dembitsky
A case report is presented of a left ventricular assist device (LVAD) recipient with a pre-existing thrombus that was removed on LVAD implant but quickly reformed and was removed, reformed again, and ultimately embolized, causing death. The thrombus formed proximal to the left ventricular outflow tract, because of the presence and subsequent repair of a calcified left ventricular infarct which had extruded from the septum. This region is vulnerable to flow stasis during LVAD support as predicted by experimental fluid mechanics studies, because of the lack of opening of the aortic valve. The presence of the repair and the altered flow field contributed to blood stasis and thrombus growth in a positive feedback loop. Although LVADs provide tremendous benefits for patients by reducing the symptoms of heart failure, the accompanying changes have some secondary consequences that remain problematic. One of these is an abnormal intraventricular flow field that decreases washout, especially in the region proximal to the left ventricular outflow tract, which is an area of flow stasis.

12 April 2016 in Meccanica
Verified
Journal Article
Closed access
PDF file
CRClaudine Reider
Claudine Reider
JMJuyeun Moon
Juyeun Moon
VRVarsha Ramesh
Varsha Ramesh
RMRicardo Montes
Ricardo Montes
JCJosue Campos
Josue Campos
KMKaren May-Newman
Karen May-Newman

10 July 2013 in ISRN Biomaterials
Verified
Journal Article
Open access
PDF file
FMF. M. Makau
F. M. Makau
Khaled MorsiKhaled Morsi
Khaled Morsi
NGN. Gude
N. Gude
RAR. Alvarez
R. Alvarez
MSM. Sussman
M. Sussman
KMKaren May-Newman
Karen May-Newman
The use of reinforcements to enhance mechanical properties of titanium such as hardness has been adopted by many researchers. Of these reinforcements, titanium boride has emerged as one of the most suitable reinforcements for titanium which is both chemically and mechanically compatible with the titanium matrix. Despite the extensive work conducted on these types of composites, very little is known about their biocompatibility which has so far precluded their use in bioapplications. The present paper investigates, for the first time, the biocompatibility of powder-processed titanium-titanium boride ( ) composites for use in medical and dental implants and basic studies on fibroblast attachment conducted to assess for this application. The work is intended to serve as an initial step towards understanding the bioresponse of these composites by evaluating cytotoxicity, cellular attachment and morphology, and hemolytic potential. Results indicate that fibroblasts attach, proliferate, and achieve confluency when in contact with the composites, exhibiting normal morphology. Furthermore, the cells show a favorable growth rate when cultured with the composite for 48 hours. The composite demonstrated excellent blood biocompatibility, with a low hemolysis level (0.12% ) when compared with CP Ti (0.17%) and Ti-6Al-4V (0.36%). These findings suggest that composite is biocompatible and further investigation into its suitability as a biomaterial should be considered.